Dirk Tomsitz
Impact in
- Immunology and Allergy top 10%
- Food Allergy and Anaphylaxis Research
- Allergic Rhinitis and Sensitization
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 3
- Cutaneous Melanoma Detection and Management 1
-
- Drug-Induced Adverse Reactions 2
- Co-authors
- Lucie Heinzerling (9 shared papers)Lars E. French (13 shared papers)Knut Brockow (4 shared papers)M.D. Anliker (1 shared paper)Lucie Heinzerling (8 shared papers)Michael Sachse (2 shared papers)Katharina Schilbach (2 shared papers)Katharina C. Kähler (2 shared papers)
- Journals
- European Journal of Cancer (4 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (4 papers)British Journal of Dermatology (2 papers)Journal of Immunotherapy (2 papers)Cancers (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Dirk Tomsitz
19 papers receiving 234 citations
Peers
Comparison fields: 5 of 48
- Immunology and Allergy 41
- Oncology 94
- Dermatology 28
- Pharmacology 32
- Immunology 32
Countries citing papers authored by Dirk Tomsitz
This map shows the geographic impact of Dirk Tomsitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Tomsitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Tomsitz more than expected).
Fields of papers citing papers by Dirk Tomsitz
This network shows the impact of papers produced by Dirk Tomsitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Tomsitz. The network helps show where Dirk Tomsitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Tomsitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 47 | |
| 2 | 2024 | 31 | |
| 3 | 2011 | 30 | |
| 4 | 2019 | 24 | |
| 5 | 2023 | 22 | |
| 6 | 2017 | 18 | |
| 7 | 2022 | 13 | |
| 8 | 2015 | 8 | |
| 9 | 2024 | 8 | |
| 10 | 2020 | 7 | |
| 11 | 2022 | 5 | |
| 12 | Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis. | 2017 | 5 |
| 13 | 2024 | 3 | |
| 14 | 2024 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 0 |
About Dirk Tomsitz
Dirk Tomsitz is a scholar working on Oncology, Pharmacology, Dermatology, Immunology and Infectious Diseases, having authored 25 papers that have together received 236 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (3 papers), Parvovirus B19 Infection Studies (2 papers), Dermatological and COVID-19 studies (2 papers), Immunotherapy and Immune Responses (2 papers), Drug-Induced Adverse Reactions (2 papers), Allergic Rhinitis and Sensitization (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Immunology and Allergy (41 citations), Oncology (94 citations), Dermatology (28 citations), Pharmacology (32 citations) and Immunology (32 citations). Dirk Tomsitz has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Lucie Heinzerling, Lars E. French, Knut Brockow, M.D. Anliker, Lucie Heinzerling, Michael Sachse, Katharina Schilbach, Katharina C. Kähler, Tilo Biedermann and Julia K. Tietze. Their work appears in journals such as European Journal of Cancer, JDDG Journal der Deutschen Dermatologischen Gesellschaft, British Journal of Dermatology, Journal of Immunotherapy and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.